|
Untitled Document
Javascript OMICS Publishing Group
|
Scientific Programme |
|
Scientific Programme - 22 Nov 2010 |
Theme:Biomarkers in Clinical Research
Dates : 22-23 November 2010
Venue: Santa Clara, California, USA.
Tel: +1-650-268-9744
Fax: +1-650-618-1414
Toll Free: +1-800-216-6499
Website: https://www.omicsonline.org/biomarkers2010/
: BIOMARKERS-2010 is comprised of Six Tracks designed to offer comprehensive sessions that address current issues in Biomarkers. You can register a whole conference or select a single track or register for special service package that you want for your participation. Now the program is under developing from viewing submitted abstracts. Proposed or related topics as below are accepted.
|
Keynote Forum |
Time: 22 November 2010, Monday, 09:00-12:05
Place: Marriott Santa Clara, Santa Clara, California, U.S.A |
9:00-10:00 |
Opening Ceremony |
Track 1: Biomarkers Classification & Molecular Sequence Analysis |
November 22, 2010
(Monday)
10:15-11:35 |
Track 1-1: Protein & Prognostic Biomarkers
Place: Salons AC |
Session Chair:
 |
Dr. Steven S. Smith
Beckman Research Institute of the City of Hope, Duarte, USA |
|
Session Co-Chair:
|
Dr. Dongfeng Tan
University of Texas ,MD Anderson Cancer Center, USA |
 |
| 10:15 – 10:20 |
Session Introduction |
10:20 – 10:40
 |
Title: ProAdrenomedullin: Prognostic Marker for more rational management of patients with Sepsis and Pneumonia.
Dr. Philipp Schuetz
University Hospital Basel, Switzerland
|
 |
10:40 – 11:00
|
Title: Signature molecular biomarkers of prognosis of gastric adenocarcinoma: A study of 114 cases using genome-wide technique and FISH
Dr. Dongfeng Tan
University of Texas ,MD Anderson Cancer Center, USA
|
|
11:00 - 11:20
|
Title: Nanotechnology for Cancer Biomarker Discovery
Dr. Steven S. Smith
Beckman Research Institute of the City of Hope, Duarte, USA
|
|
11:20-11:25 |
Panel Discussion |
|
November 22, 2010
(Monday)
13:50-15:55 |
Track 1-2: Cancer Biomarkers: Emerging Biomarkers in Breast Cancer & Prostate Cancer Biomarkers
Place: Salons AC |
Session Chair:
 |
Dr. Jagat Kanwar
Institute for Technology & Research Innovation (ITRI)
Deakin University, AUSTRALIA. |
 |
Session
Co-Chair: |
Dr. Megan B. Myers
U.S. Food and Drug Administration, USA |
 |
| Session Introduction |
13:10 – 13:35
|
Title: Copro-antiapoptotic protein survivin and lactoferrin biomarkers for improved detection and monitor anti-cancer therapy in colorectal cancer.
Dr. Jagat Kanwar
Institute for Technology & Research Innovation (ITRI)
Deakin University, AUSTRALIA.
|
|
14:15-14:35
 |
Title: Lipocalin 2, a biomarker and therapeutic target for breast cancers.
Dr. Yun Wu
University of Texas M. D. Anderson Cancer Center, USA
|
|
14:35-14:55
 |
Title: Auto-antibody signatures for disease diagnosis in cancer and autoimmune diseases.
Dr. Stefan Mullner
Protagen AG, Germany
|
 |
| Coffee Break / Poster Session at Exhibition Area: Marriott Santa Clara, Santa Clara, California, U.S.A |
15:10-15:30
|
Title: Phosphoproteomic Profiling of signaling pathways in Tumor Cells by Multiplex Suspension Arrays
Dr. Imran H. Khan
University of California at Davis, USA
|
 |
15:30-15:50
|
Title: The studies on serum peptidome profiling as possible biomarker of cancer
Dr. Yaping Tian
Department of Clinical Biochemistry, Chinese PLA General Hospital, China
|
|
| 15:50-15:55 |
Panel Discussion |
|
| Cocktails / Poster Session at Exhibition Area: Marriott Santa Clara, Santa Clara, California, U.S.A |
November 22, 2010
(Monday)
11:40-12:50 |
Track 1-3: Biomarkers for Human Diseases
Place: Salons AC |
Session Chair:
 |
Dr. Rod K. Nibbe
Case Western Reserve University, USA |
 |
Session
Co-Chair:
 |
Dr. Cuiying Chitty Chen
Ghent University, Belgium |
 |
| Session Introduction |
11:45-12.05
|
Title: Network Biology: Network markers of disease – examples in human colorectal cancer.
Dr. Rod K. Nibbe
Case Western Reserve University, USA
|
|
12:05-12:25
 |
Title:Measurement of Angiogenesis Promotors and Cytokines Concentrations in Intraocular Fluid of Patients with Proliferative Diabetic Retinopathy
Dr. Jindra Vrzalova
Immunoanalytic Laboratory and Eye Department of University Hospital and Medical Faculty in Pilsen, Czech Republic
|
|
12:25-12:45
|
Title: N-glycomics biomarker: new test for human ageing and age-related diseases?
Dr. Cuiying Chitty Chen
Ghent University, Belgium
|
|
| 12:45-12:50 |
Panel Discussion |
|
November 22, 2010
(Monday)
16:00-17:30 |
Track 1-4: Blood Biomarkers: Serum Biomarkers & Blood Cells RNA Biomarkers
Place: Salons AC |
Session Chair:
|
Dr. Philipp Schuetz
University Hospital Basel, Switzerland |
|
Session
Co-Chair:
 |
Dr. Matthias Scheffler
Febit holding gmbh, Germany |
 |
| Session Introduction |
16:05-16:25
 |
Title: Adiponectin as a Biomarker for Impaired Fasting Glucose among Non-Obese Populations.
Dr. Sun Ha Jee
Yonsei University, Korea
|
 |
16:25-16:45
|
Title: miRNA biomarker for ovarian cancer screening
Dr. Matthias Scheffler
Febit holding gmbh, Germany
|
|
16:45-17:05
 |
Title: Procalcitonin: Marker & Mediator in Sepsis & Guide for Antibiotic Therapy in Respiratory Infections.
Dr. Philipp Schuetz
University Hospital Basel, Switzerland
|
 |
17:05-17:25
 |
Title: Diagnostic Utility of Procalcitonin as a Biomarker of Sepsis.
Dr. Mina Hur
Konkuk University School of Medicine, Seoul, Korea
|
 |
| 17:25-17:30 |
Panel Discussion |
| Coffee Break / Poster Session at Exhibition Area: Marriott Santa Clara, Santa Clara, California, U.S.A |
| Track 2: Biomarkers in Clinical Research & Development |
November 22, 2010
(Monday)
10:15-12:00 |
Track 2-1(i): Cancer Science & Therapy
2-1(ii): Biomarkers in Endocrinology & Metabolism
Place: Salons D-E |
Session Chair:  |
Dr. Dhara Macdermed
Physician, Division of Radiation Oncology
Scripps Clinic/ Scripps Green Hospital La Jolla, CA |
 |
Session
Co-Chair:
 |
Dr. Samy L Habib
University of Texas, USA |
 |
| Session Introduction |
10:20-10:40
|
Title: Advances and Challenges in Cancer Genomics and Transcriptomics.
Dr. Dhara Macdermed
Physician, Division of Radiation Oncology
Scripps Clinic/ Scripps Green Hospital La Jolla, CA
|
 |
10:40-11:00
|
Title: Role of Rapamycin in Tumorigenesis.
Samy L Habib
University of Texas ,USA
|
 |
| Coffee Break / Poster Session at Exhibition Area: Marriott Santa Clara, Santa Clara, California, U.S.A |
11:15-11:35
 |
Title: Aberrant crypt foci as a biomarker of colonic neoplasia: Role in cancer prevention
Dr. Ranjana Bird
University of Windsor, Windsor, Canada
|
 |
11:35-11:55
|
Title: MBDP Metabolic Biomarkers Discovery Project
Dr. Vladimir V. Tolstikov
UC Davis Genome Center, USA |
 |
| 11:55-12:00 |
Panel Discussion |
|
| Lunch at Exhibition Area: Marriott Santa Clara, Santa Clara, California, U.S.A |
November 22, 2010
(Monday)
12:05-14:35 |
|
Session Chair:
 |
Dr. Jing-Gung Chung
Department of Biological Science and Technology, China Medical University, Taiwan |
 |
Session
Co-Chair:
 |
Dr. Anna Tompa
Semmelweis Medical University,Budapest, HUNGARY. |
 |
| Session Introduction |
12:10-12:30
|
Title: Blocking of IGF-1R signaling by a novel quinazoline derivative (LJJ-30) inhibits metastasis and induces mesenchymal-epithelial transition in osteosarcoma cells
Dr. Jing-Gung Chung
Department of Biological Science and Technology, China Medical University, Taiwan
|
|
12:30-12:50
|
Title: Biomarkers in Cancer Chemoprevention.
Dr. Anna Tompa
Semmelweis Medical University,Budapest, HUNGARY.
|
|
| Lunch at Exhibition Area: Marriott Santa Clara, Santa Clara, California, U.S.A |
13:50 -14:10 |
Title: RNAi-mediated downregulation of UHRF1 results in decreased human breast cancer cell growth.
Dr. Feng Yan
Jiangsu Institute of Cancer Prevention and Cure, PR China
|
|
14:10-14:30
 |
Title: Interpretation of biomarkers with help of computer program - yes or no?
Dr. Ondrej Topoclan
Medical faculty of Charles University, Czech Republic
|
 |
| 14:30-14:35 |
Panel Discussion |
| Coffee Break / Poster Session at Exhibition Area: Marriott Santa Clara, Santa Clara, California, U.S.A |
November 22, 2010
(Monday)
14:50-17:00 |
Track 2(v): Transplantation Immunology
2(vi): Central Nervous System
Place: Salons D-E |
Session Chair:
|
Dr. Paul Wood
President & CEO, Phreedom Pharma Inc, Canada |
 |
Session
Co-Chair:
 |
Dr. Da Liu
University of California at Davis, CA, USA
|
 |
| 14:55-15:15 |
Title: The Determination of Serum and Cerebrospinal Fluid Visin like protein-I Utilized in the Diagnostics of the stroke– A Pilot Study.
Dr. David Stejskal
Central Moravian hospital county Inc., Czech Republic
|
|
15:15-15:35
|
Title: Membrane Plasmalogen Augmentation as a New Strategy for Treating Alzheimer’s Disease.
Dr. Paul Wood
President & CEO, Phreedom Pharma Inc, Canada
|
|
15:35-15:55
|
Title: Biomarkers for Stroke Subgroups in Blood.
Dr. Da Liu
University of California at Davis, CA, USA
|
|
15:55-16:15
 |
Title: Application of biomarkers for the personalized management of neurological disorders.
Dr. Kewel K. Jain
Jain PharmaBiotech, 4057 Basel, Switzerland
|
|
16:15-16:35
 |
Title: Diagnostic Biomarkers for Traumatic Brain injury; from proteomics, systems biology, animal studies to clinical validation.
Dr. Kevin K. W. Wang
Center of Innovative Research, BANYAN BIOMARKERS Inc, USA
|
 |
16:35-16:55
 |
Title: TIP-1 as one biomarker of tumor progression and radiation sensitivity within malignant glioma
Dr. Zhaozhong Han
Vanderbilt University School of Medicine,USA.
|
 |
| Panel Discussion |
| Cocktails / Poster Session at Exhibition Area: Marriott Santa Clara, Santa Clara, California, U.S.A |
|
|
|
|
|
University of Texas M. D. Anderson Cancer Center, USA
Federal University of Minas Gerais, Brazil
Deakin University, Australia
University of Rochester, USA
Ghent University, Belgium
Case Western Reserve University, USA
Konkuk University School of Medicine, Korea
University of Texas, USA
Universidad Católica de Valencia San Vicente Mártir, Spain
Semmelweis Medical University, Hungary
China Medical University, Taiwan
University of Calgary, Canada
An-Najah National University-School of Medicine, Palestine
Santosh University, India
University of Colorado, USA
University of California at Davis, USA
Post Graduate Institute of Medical Education & Research, India
University of New South Wales, Australia
Keio University, Japan
Universiti Sains Malaysia (USM), Malaysia
Cairo University, Egypt
Panjab University, India
Southern Methodist University, USA
Northeastern University, USA
Charité – Universitätsmedizin Berlin, Germany
Yonsei University, Korea
Chhatrapati Shahuji Maharaj Medical University, India
Jawaharlal Nehru University, India
|
U.S. Food and Drug Administration, USA
Protagen AG, Germany
Shanxi Cancer Institute, China
Cellular Technology Ltd., USA
Scripps Clinic/ Scripps Green Hospital, USA
UC Davis Genome Center, USA
Jiangsu Institute of Cancer Prevention and Cure, PR China
Biosystems International SAS, France
Sunnybrook Health Sciences Center, USA
Phreedom Pharma Inc, Canada
Jain PharmaBiotech, Switzerland
BANYAN BIOMARKERS Inc, USA
Prostějov Hospital, Central Moravian hospital county Inc., Czech Republic
National Research Centre, Egypt
Metropolitan Administration Medical College and Vajira Hospital, Thailand
CNS Research, NeuroSearch A/S, USA
Phenomenome Discoveries Inc, Canada
L. Boltzmann Institute für experimentelle und klinische Traumatologie, Austria
Baylor Health Care System Institute for Health Care Research and Improvement, USA
Capital Medical University, China
Quality Engineering Education, Incorporated, USA
Febit holding gmbh, Germany
|
|
|
|
